New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...
The public debate on cannabis is dominated by a tone of normalization—less stigmatization, more freedom of choice. The ...
From the spice rack to the lab bench, emerging proteomic insights reveal how hidden peptide fragments in everyday spices may ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...
FEBRUARY 5, 2026, NEW YORK - It is with sadness that we share news of the death of Richard Hynes, Daniel K. Ludwig Professor for Cancer Research ...
17h
Study by Indian researchers finds that body’s immune cells ‘betray’ it to help breast cancer spread
Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...
Blood flows around the body through a complex network of vessels, which must constantly adapt to changing needs. The balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results